References
- Ramasamy K, Raman R, Tandon M. Current state of care for diabetic retinopathy in India. Curr Diab Rep 2013 Aug;13(4):460--468. doi:10.1007/s11892-013-0388-6
- Simmons D, Clover G, Hope C. Ethnic differences in diabetic retinopathy. Diabet Med 2007;24(10):1093–1098. doi:10.1111/j.1464-5491.2007.02227.x
- Brian G, Ramke J, Maher L, et al. The prevalence of diabetes among adults aged 40 years and over in Fiji. N Z Med J 2010;123(1327):1–9
- Zimmet P, Taylor R, Ram P, et al. Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol 1983;118(5):673–688. Available at: http://www.ncbi.nlm.nih.gov/pubmed/6637994
- Namperumalsamy P, Kim R, Vignesh TP, et al. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Postgrad Med J 2009;85(1010):643–648. doi:10.1136/bjo.2008.147934
- Raman R, Rani PK, Reddi Rachepalle S, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009;116(2):311–318. doi:10.1016/j.ophtha.2008.09.010
- Ramke J, Qoqonokana MQ, Brian G. Diabetes and its ocular complications in Timor-Leste. Clin Experiment Ophthalmol 2011 Nov;39(8):843–844. doi:10.1111/j.1442-9071.2011.02533
- International Diabetes Federation. International Diabetes Atlas, 6th edn. Brussels, Belgium; 2013. Available at: http://www.idf.org/diabetesatlas
- Clover G. Diabetes screening, grading and management guidelines for use in Pacific Island nations. 2009;(c) Available at: http://www.icoph.org/dynamic/attachments/taskforce_documents/2013_pacific_island_ret_screen_guidelines_2010.doc
- Diabetes retinal screening, grading and management guidelines for use in Pacific Island nations 2010. Available at: http://www.icoph.org/dynamic/attachments/taskforce_documents/2013_pacific_island_ret_screen_guidelines_2010.doc
- National diabetes retinal screening grading system and referral guidelines. Wellington Ministry of Health, 2006. Available at: http://www.health.govt.nz/publication/national–dia
- World Health Organization. Coding Instructions for the WHO/PBL eye examination record (Version III). Geneva: WHO, 1988
- Namperumalsamy P, Nirmalan PK, Ramasamy K. Developing a screening program to detect sight-threatening diabetic retinopathy in South India. Diabetes Care 2003;26(6):1831–1835. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12766118
- Polack S, Yorston D, López-Ramos A, et al. Rapid assessment of avoidable blindness and diabetic retinopathy in Chiapas, Mexico. Ophthalmology 2012;119(5):1033–1040. doi:10.1016/j.ophtha.2011.11.002
- Adler I, Stratton IM, Neil H, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321(7258):412–419. Available at: http://www.pubmedcentral.nih.gov/articlerender.cgi?artid=27455&tool=pmcentrez&rendertype=abstract
- Kaufman SC, Ferris FL, Seigel DG, Davis MD. Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Invest Ophthalmol Vis Sci 1989 Jan;30(1):23--28
- Klein R, Klein BEK, Moss SE, Linton KLP. The Beaver Dam Eye Study. Ophthalmology 1992;99(1):58–62. doi:10.1016/S0161-6420(92)32011-1
- Brian G, Sikivou B, Fischer-Harder K, et al. Diabetic eye disease among adults in Fiji with previously undiagnosed diabetes. Clin Experiment Ophthalmol 2011;39(7):682–690. doi:10.1111/j.1442-9071.2011.02533.x
- Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 2012;12(4):346–354. doi:10.1007/s11892-012-0283-6
- Rajendram R, Fraser-Bell S, Kaines A, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. Arch Ophthalmol 2012;130(8):972–979. doi:10.1001/archophthalmol.2012.393
- Jimenez-Ramirez F, Perez R. Diabetic retinopathy education and screening at the community pharmacy in Puerto Rico. P R Health Sci J 2011;30(3):139–144